These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 14607794

  • 1. Nerve excitability properties in Charcot-Marie-Tooth disease type 1A.
    Nodera H, Bostock H, Kuwabara S, Sakamoto T, Asanuma K, Jia-Ying S, Ogawara K, Hattori N, Hirayama M, Sobue G, Kaji R.
    Brain; 2004 Jan; 127(Pt 1):203-11. PubMed ID: 14607794
    [Abstract] [Full Text] [Related]

  • 2. Altered axonal excitability properties in amyotrophic lateral sclerosis: impaired potassium channel function related to disease stage.
    Kanai K, Kuwabara S, Misawa S, Tamura N, Ogawara K, Nakata M, Sawai S, Hattori T, Bostock H.
    Brain; 2006 Apr; 129(Pt 4):953-62. PubMed ID: 16467388
    [Abstract] [Full Text] [Related]

  • 3. [Molecular pathology of Charcot-Marie-Tooth disease type 1A: abnormal expression of PMP-22].
    Yoshikawa H, Nishimura T, Yanagihara T.
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1441-3. PubMed ID: 8752424
    [Abstract] [Full Text] [Related]

  • 4. Threshold electrotonus in chronic inflammatory demyelinating polyneuropathy: correlation with clinical profiles.
    Sung JY, Kuwabara S, Kaji R, Ogawara K, Mori M, Kanai K, Nodera H, Hattori T, Bostock H.
    Muscle Nerve; 2004 Jan; 29(1):28-37. PubMed ID: 14694495
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Differences in potentials and excitability properties in simulated cases of demyelinating neuropathies. Part I.
    Stephanova DI, Daskalova M, Alexandrov AS.
    Clin Neurophysiol; 2005 May; 116(5):1153-8. PubMed ID: 15826856
    [Abstract] [Full Text] [Related]

  • 7. Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1a sural nerve biopsies.
    Hanemann CO, Stoll G, D'Urso D, Fricke W, Martin JJ, Van Broeckhoven C, Mancardi GL, Bartke I, Müller HW.
    J Neurosci Res; 1994 Apr 01; 37(5):654-9. PubMed ID: 8028042
    [Abstract] [Full Text] [Related]

  • 8. Nerve excitability changes in critical illness polyneuropathy.
    Z'Graggen WJ, Lin CS, Howard RS, Beale RJ, Bostock H.
    Brain; 2006 Sep 01; 129(Pt 9):2461-70. PubMed ID: 16901913
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Axonal excitability properties in amyotrophic lateral sclerosis.
    Vucic S, Kiernan MC.
    Clin Neurophysiol; 2006 Jul 01; 117(7):1458-66. PubMed ID: 16759905
    [Abstract] [Full Text] [Related]

  • 11. Charcot-Marie-Tooth disease type 1A: molecular mechanisms of gene dosage and point mutation underlying a common inherited peripheral neuropathy.
    Roa BB, Garcia CA, Lupski JR.
    Int J Neurol; 2006 Jul 01; 25-26():97-107. PubMed ID: 11980069
    [Abstract] [Full Text] [Related]

  • 12. A rat model of Charcot-Marie-Tooth disease 1A recapitulates disease variability and supplies biomarkers of axonal loss in patients.
    Fledrich R, Schlotter-Weigel B, Schnizer TJ, Wichert SP, Stassart RM, Meyer zu Hörste G, Klink A, Weiss BG, Haag U, Walter MC, Rautenstrauss B, Paulus W, Rossner MJ, Sereda MW.
    Brain; 2012 Jan 01; 135(Pt 1):72-87. PubMed ID: 22189569
    [Abstract] [Full Text] [Related]

  • 13. Myelin protein zero gene dose dependent axonal ion-channel dysfunction in a family with Charcot-Marie-Tooth disease.
    Moldovan M, Pisciotta C, Pareyson D, Krarup C.
    Clin Neurophysiol; 2020 Oct 01; 131(10):2440-2451. PubMed ID: 32829291
    [Abstract] [Full Text] [Related]

  • 14. Changes in excitability properties associated with axonal regeneration in human neuropathy and mouse Wallerian degeneration.
    Sawai S, Kanai K, Nakata M, Hiraga A, Misawa S, Isose S, Hattori T, Kuwabara S.
    Clin Neurophysiol; 2008 May 01; 119(5):1097-105. PubMed ID: 18342570
    [Abstract] [Full Text] [Related]

  • 15. Differences in potentials and excitability properties in simulated cases of demyelinating neuropathies. Part III. Paranodal internodal demyelination.
    Stephanova DI, Daskalova M.
    Clin Neurophysiol; 2005 Oct 01; 116(10):2334-41. PubMed ID: 16122981
    [Abstract] [Full Text] [Related]

  • 16. Axonal excitability in X-linked dominant Charcot Marie Tooth disease.
    Liang C, Howells J, Kennerson M, Nicholson GA, Burke D, Ng K.
    Clin Neurophysiol; 2014 Jun 01; 125(6):1261-9. PubMed ID: 24290847
    [Abstract] [Full Text] [Related]

  • 17. Congenital pes cavus in a Charcot-Marie-tooth disease type 1A newborn.
    Fusco C, Frattini D, Scarano A, Giustina ED.
    Pediatr Neurol; 2009 Jun 01; 40(6):461-4. PubMed ID: 19433282
    [Abstract] [Full Text] [Related]

  • 18. Elevated expression of messenger RNA for peripheral myelin protein 22 in biopsied peripheral nerves of patients with Charcot-Marie-Tooth disease type 1A.
    Yoshikawa H, Nishimura T, Nakatsuji Y, Fujimura H, Himoro M, Hayasaka K, Sakoda S, Yanagihara T.
    Ann Neurol; 1994 Apr 01; 35(4):445-50. PubMed ID: 7512319
    [Abstract] [Full Text] [Related]

  • 19. Diabetes mellitus exacerbates motor and sensory impairment in CMT1A.
    Sheth S, Francies K, Siskind CE, Feely SM, Lewis RA, Shy ME.
    J Peripher Nerv Syst; 2008 Dec 01; 13(4):299-304. PubMed ID: 19192070
    [Abstract] [Full Text] [Related]

  • 20. A large family with Charcot-Marie-Tooth Type 1a and Type 2 diabetes mellitus.
    Koç F, Sarica Y, Yerdelen D, Baris I, Battaloglu E, Sert M.
    Int J Neurosci; 2006 Feb 01; 116(2):103-14. PubMed ID: 16393877
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.